Clinical trials
Phase 4 Sarcopenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 4 |
| Terminated | 2 |
| Recruiting | 2 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Texas Medical Branch, Galveston | 2 |
| Boston Medical Center | 1 |
| Erasmus Medical Center | 1 |
| Federal University of Juiz de Fora | 1 |
| Gumi Cha Medical Center | 1 |
| Hospital Clinic of Barcelona | 1 |
| Hungarian Institute of Cardiology | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| Lijun Yang | 1 |
| Manchester University NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcopenia | 20 |
| Frailty | 2 |
| Anemia | 1 |
| Bone Diseases, Metabolic | 1 |
| Cachexia | 1 |
| Crohn Disease | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Fatigue | 1 |
| Hip Fractures | 1 |
| Hypogonadism | 1 |
Trials
Showing 51 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.